Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rasarfin
Cat. No.:
OB0225LY-0065
Appearance:
Solid
Purity:
≥97%
Identity:
Confirmed by NMR and LC-MS.
Size:
Product Overview
Description:
Rasarfin is a novel anti-tumor compound with multi-targeted effects that affect the proliferation and survival of cancer cells. It enhances the sensitivity of cancer cells to treatment by modulating multiple signaling pathways.
Synonym:
674359-73-0; N-[3-Chloro-4-[4-(2-methylpropanoyl)piperazin-1-yl]phenyl]-1-benzofuran-2-carboxamide; N-(3-Chloro-4-(4-isobutyrylpiperazin-1-yl)phenyl)benzofuran-2-carboxamide; 2-Benzofurancarboxamide, N-[3-chloro-4-[4-(2-methyl-1-oxopropyl)-1-piperazinyl]phenyl]-
CAS No.:
674359-73-0
Compound CID:
1396167
Formula:
C23H24ClN3O3
Formula Weight:
425.91
Specification
Relative Density:
1.309 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Rasarfin can be used for tumor-related signaling pathway regulation.
Library Information
Targets:
GTPase superfamily
Receptors:
ARF6; Ras
Pathways:
GPCR/G protein; MAPK
Plate Number:
AOCL-1
Plate Location:
g7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 140.87 mM
